Company filings profile · CIK 0001501697
X4 Pharmaceuticals, Inc — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for X4 Pharmaceuticals, Inc (XFOR): 15 filings in the last 90 days vs 14 in the prior 90 (filing-velocity steady · 1.07×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Oct 9, 2026. Source-linked, daily-refreshed.
Material 8-K events — X4 Pharmaceuticals, Inc
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Oct 8, 2026 | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Sep 9, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | Other Events; Financial Statements and Exhibits | ↗ |
| Jul 1, 2026 | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 12, 2026 | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
Watch X4 Pharmaceuticals, Inc automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Oct 8, 2026 | 8-K | Entry into a Material Agreement; Termination of a Material Agreement; Material Direct Financial Obligation; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Oct 7, 2026 | SCHEDULE 13G/A | ↗ | |
| Oct 5, 2026 | 4 | FORM 4 | ↗ |
| Oct 1, 2026 | 144 | ↗ | |
| Sep 21, 2026 | SCHEDULE 13G | ↗ | |
| Sep 9, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Sep 8, 2026 | 8-K | Other Events; Financial Statements and Exhibits | ↗ |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 14, 2026 | SCHEDULE 13G/A | ↗ | |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 4 | FORM 4 | ↗ |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 13, 2026 | 144 | ↗ | |
| Aug 6, 2026 | 10-Q | 10-Q | ↗ |
| Jul 30, 2026 | SCHEDULE 13G | ↗ | |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 4 | FORM 4 | ↗ |
| Jul 1, 2026 | 3 | FORM 3 | ↗ |
| Jul 1, 2026 | 8-K | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 14, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 13, 2026 | 8-K/A | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 13, 2026 | 4 | FORM 4 | ↗ |
| May 12, 2026 | 144 | ↗ | |
| May 12, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07 | ↗ |
| May 12, 2026 | CORRESP | ↗ | |
| May 11, 2026 | UPLOAD | ↗ | |
| May 6, 2026 | S-3 | S-3 | ↗ |
| May 6, 2026 | 10-Q | 10-Q | ↗ |
| Mar 20, 2026 | ARS | ARS | ↗ |
| Mar 20, 2026 | DEFA14A | DEFA14A | ↗ |
| Mar 20, 2026 | DEF 14A | DEF 14A | ↗ |
| Mar 18, 2026 | S-8 | S-8 | ↗ |
| Mar 17, 2026 | 10-K | 10-K | ↗ |
| Mar 6, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G/A | ↗ | |
| Feb 17, 2026 | SCHEDULE 13G | ↗ | |
| Feb 13, 2026 | SCHEDULE 13G/A | ↗ |